Skip to main content
Organigram Holdings Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.540
-0.010 (-0.65%)
Jan 21, 2025, 4:00 PM EST - Market closed

Organigram Holdings Revenue

In the fiscal year ending September 30, 2024, Organigram Holdings had annual revenue of 159.84M CAD with 7.13% growth. Organigram Holdings had revenue of 44.70M in the quarter ending September 30, 2024, with 36.34% growth.

Revenue (ttm)
159.84M CAD
Revenue Growth
+0.69%
P/S Ratio
n/a
Revenue / Employee
177,997 CAD
Employees
898
Market Cap
197.46M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Sep 30, 2024159.84M10.64M7.13%
Sep 30, 2023149.21M3.40M2.33%
Aug 31, 2022145.81M66.65M84.19%
Aug 31, 202179.16M-7.63M-8.79%
Aug 31, 202086.80M6.38M7.94%
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro
Aug 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 87.70B
Merck & Co. 63.17B
AbbVie 55.53B
AstraZeneca 51.21B
Novartis AG 49.94B
Thermo Fisher Scientific 42.37B
Abbott Laboratories 41.22B
Revenue Rankings

OGI News

More News